Repetitive Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Breast and Gynecologic Cancer Survivors: A Pilot Study
University of Utah
Summary
The goal of this study is to evaluate the change in pain scores among patients with chemotherapy-induced peripheral neuropathy after receiving treatment with repetitive transcranial magnetic stimulation (rTMS).
Eligibility
- Age range
- 18+ years
- Sex
- Female
- Healthy volunteers
- No
Inclusion Criteria: * Female subjects aged ≥ 18 years. * Histologically confirmed breast or gynecologic cancer. * Developed neuropathic pain with the initiation of or within one month after completion of treatment with anti-neoplastic agents from the following class: * Platinum-based drugs * Taxanes * Vinca alkaloids * Pain score 4 or more on the Pain Numeric Rating Scale (PNRS). * Score 3 or more on the Douleur Neuropathique 4 (DN-4) questionnaire. * Persistent neuropathic pain with current use of at least one neuropathic medication. * Subjects must have been on a stable dose of neuro…
Interventions
- DevicerTMS
Repetitive Transcranial Magnetic Stimulation will be administered Monday-Friday for two weeks (10 sessions total)
Location
- Huntsman Cancer Institute at University of UtahSalt Lake City, Utah